balstilimab,botensilimab
agenus
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'balstilimab', 'botensilimab', 'effector ', 'adaptive ']
phase 1 trial of botensilimab, a multifunctional anti-ctla-4, + balstilimab (anti-pd-1) for heavily pretreated #mcrc at #wcgic2023 deep &amp; durable responses higher efficacy in pts without liver mets randomized phase 2 (nct05608044) ongoing 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology